Summary
Non-Hodgkin's lymphoma (NHL) is a group of malignancies that develop in lymphoid tissues, mainly in the lymph nodes. These tumors can be caused by chromosomal translocations, toxins, chronic inflammation, and infections.
Introduction
...
Summary
The highest incidence of Non-Hodgkin's lymphoma (NHL) is in countries with high human development rates, such as Western Europe, North America and Australia. However, the incidence of NHL in 2012 was estimated at 2.2 / 100,000 (23,801 new...
Summary
Due to the poorly understood aetiology of Non-lymphoma, Hodgkin's identifying risk factors for NHL is difficult (NHL). However, research has shown that certain clinical and environmental factors, as well as genetic factors, are linked to ...
Summary
Although there is no safe way known to prevent non-Hodgkin's lymphoma (NHL), limiting exposure to certain chemicals and drugs, avoiding certain viral infections, and avoiding radiation exposure may reduce the risk of NHL.
Introduction
...
Summary
Non-Hodgkin's lymphoma (NHL) can cause various signs and symptoms depending on the type of NHL and its location in the body. Some of the common symptoms of NHL includes swollen lymph nodes, fever, cough, shortness of breath, chest pain, s...
Summary
Diagnosis of Non-Hodgkin’s Lymphoma (NHL) is usually done using traditional methods such as clinical laboratory testing, lymph node biopsy, bone marrow aspiration, immunophenotyping and imaging methods. However, in recent times molecula...
Summary
The stage of non-Hodgkin's lymphoma (NHL) is a process that determines the number of lymph nodes affected, the location of cancer, and the organs or regions where cancer has spread from the original site such as the lungs or liver. Howeve...
Summary
A large number of treatment options are available for people with non-Hodgkin's lymphoma (NHL). The types of standard treatment for NHL includes radiation therapy, immunotherapy, chemotherapy, surgery, targeted therapy, stem cell/bone mar...
Summary
Clinical trials on Non Hodgkin’s Lymphoma (NLH) are also required to determine new therapeutic drugs and treatment options for patients. NHL clinical trials are required to acquire more information about the representativeness of patien...
Coping with Treatment for Non-Hodgkin's Lymphoma (NHL)
Summary
Undoubtedly, patients with non-Hodgkin lymphoma (NHL) face major challenges whilst undergoing treatment for cancer. Patients face common difficulties due to NHL treatment. In other words, these difficulties include coping with the treatme...
Follow up care for Non-Hodgkin's Lymphoma Treatment
Summary
After completing the primary treatment for Non-Hodgkin's Lymphoma, survivors usually visit a doctor or cancer care provider. In other words, they go for regular check-ups and consultations. There are various types of follow ups for cancer...
Summary
Non-Hodgkin's lymphoma (NHL) is the sixth most common malignancy in the UK, with 13,000 new cases diagnosed each year. However, after being diagnosed, approximately 65% of cancer patients live for 5 years or more years in the United Kingd...
It is essential for the patients to have an honest, open discussions with the doctor or the cancer care team. Undoubtedly, the patient should ask any question, no matter how minor it might seem. Likewise, here are some questions patients with non-H...
Non-Hodgkin’s Lymphoma
